MedPath
NMPA Approval

Henagliflozin Proline Tablets

国药准字H20210052

December 31, 2021

Drug Information

脯氨酸恒格列净片

瑞沁

片剂

5mg(按C22H24ClFO7计)

化学药品

December 31, 2021

Company Information

Applicant Company

连云港经济技术开发区黄河路38号

Manufacturing Company

连云港经济技术开发区黄河路38号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

脯氨酸恒格列净片 - NMPA 批准文号 | MedPath